WARSAW, Ind.--(BUSINESS WIRE)--
Biomet, Inc. announced today that it will be participating in the Bank of America Merrill Lynch 2013 Leveraged Finance Conference in Boca Raton, Florida on Tuesday, December 3, 2013 at 2:50 p.m. local time.
A link to the presentation will be available on Biomet’s website at www.biomet.com in the Investor Section.
Biomet, Inc. and its subsidiaries design, manufacture and market products used primarily by musculoskeletal medical specialists in both surgical and non-surgical therapy. Biomet's product portfolio includes knee and hip reconstructive products; sports medicine, extremities and trauma products; spine, bone healing and microfixation products, including spine hardware, spinal stimulation devices, osteobiologics, and non-invasive bone growth stimulators; as well as neurosurgical and craniomaxillofacial reconstructive devices, and thoracic products; dental reconstructive products; and bone cement products, biologics, and other products. Headquartered in Warsaw, Indiana, Biomet and its subsidiaries currently distribute products in approximately 90 countries.
Daniel P. Florin, Senior Vice President and Chief Financial Officer, 574-372-1687
Barbara Goslee, Director, Investor Relations, 574-372-1514